CCSD code A7520 – Thoracic sympathectomy billing guide

Key takeaways

CCSD Code A7520 covers a diagnostic thoracic sympathetic block using local anaesthetic under X-ray control.

Fluoroscopic guidance is part of the code descriptor, so a missing confirmation line in the operative note is the leading cause of rejection.

Clinical indications include primary hyperhidrosis, Raynaud’s phenomenon, and complex regional pain syndrome where the clinician suspects sympathetic mediation.

The neighbouring codes A7500, A7530 and A7600 are all lumbar, so none of them covers a thoracic block.

Pabau’s procedure documentation and pre-authorisation tracking help private practice teams submit clean A7520 claims.

CCSD Code A7520: definition and code scope

CCSD Code A7520 sits in the sympathetic nerves category of the UK private practice coding schedule maintained by the Clinical Coding and Schedule Development group. Its official descriptor is: Thoracic sympathectomy diagnostic (local anaesthetic under X-ray control). Every word in that descriptor carries billing significance.

• Thoracic: the target is the thoracic sympathetic chain, specifically the ganglia located adjacent to the thoracic vertebrae (most commonly T2-T4 for upper-limb indications).
• Sympathectomy diagnostic: the code covers a temporary interruption of sympathetic conduction for prognostic purposes. It is not a neurolytic or ablative procedure.
• Local anaesthetic: the injected agent must be a local anaesthetic (such as bupivacaine or lidocaine). This code does not capture phenol, alcohol, or radiofrequency energy.
• Under X-ray control: the procedure requires fluoroscopic guidance. A blind approach does not satisfy the descriptor, and UK private medical insurers will reject it.

The CCSD official schedule groups A7520 with the lumbar sympathectomy codes, both diagnostic and therapeutic. Knowing where A7520 sits in that family matters when the clinical picture moves from a diagnostic block to definitive treatment.

What the procedure involves: thoracic sympathectomy under X-ray control

The procedure targets the thoracic sympathetic chain, a paired structure running lateral to the vertebral bodies along the posterior mediastinum. Under CCSD Code A7520, the clinician performs the block with fluoroscopic imaging active throughout needle placement to confirm accurate positioning before injection.

1. Patient positioning: prone or lateral decubitus, depending on the operator’s preference and the patient’s body habitus. The clinician prepares the skin and applies sterile draping.
2. Fluoroscopy setup: C-arm or fixed fluoroscopy unit confirms vertebral level. The clinician confirms the target in both anteroposterior and lateral projections before needle advancement.
3. Needle placement: the clinician advances a spinal needle under continuous fluoroscopic guidance. The target is the anterolateral aspect of the thoracic vertebral body, adjacent to the sympathetic chain. The clinician may inject contrast medium to confirm spread pattern and exclude intravascular placement.
4. Local anaesthetic injection: after confirming needle position under X-ray control, the clinician administers a defined volume of local anaesthetic. The clinician must document the agent and volume in the operative note.
5. Post-procedure observation: staff monitor the patient for haemodynamic changes, pneumothorax symptoms, and neurological effects before discharge from the procedure suite.

Fluoroscopic guidance forms part of the code descriptor itself, so the procedure billed as A7520 is the imaging-guided version of the block. A clinician performing a thoracic sympathetic block without radiological guidance is performing a different procedure and should not use this code.

Clinical indications: when is A7520 appropriate?

A7520 is appropriate when a clinician needs diagnostic confirmation that sympathetic activity drives the patient’s symptoms before committing to a definitive procedure. The block provides a temporary, reversible sympatholysis that serves as a prognostic test. Accepted clinical indications in UK private practice include:

• Primary hyperhidrosis (palmar or axillary): the most common indication for thoracic sympathectomy. A positive response to the diagnostic block predicts likely benefit from surgical or radiofrequency sympathectomy. Specialist practices managing hyperhidrosis use A7520 as the first interventional step.
• Raynaud’s phenomenon: where vasospasm of the upper-limb digital vessels is resistant to pharmacological management, a diagnostic thoracic sympathetic block assesses the degree of vasospastic component.
• Complex regional pain syndrome (CRPS/reflex sympathetic dystrophy): a diagnostic block identifies whether the pain carries a significant sympathetically maintained component. The result informs the choice between sympathectomy and spinal cord stimulation.
• Angina pectoris (refractory): left thoracic sympathectomy has a role in refractory angina where conventional treatments have failed. The clinician may perform a diagnostic block as part of the assessment pathway.
• Peripheral vascular disease: upper-limb ischaemia secondary to vasospasm may benefit from sympatholysis; a diagnostic block confirms vascular response before the team considers surgical sympathectomy.

Insurers will look for a documented indication on every A7520 claim. A vague entry such as “upper limb pain” without a confirmed or working diagnosis will trigger a clinical review request and may result in rejection.

Diagnostic vs therapeutic: understanding the code’s scope

The distinction between diagnostic and therapeutic sympathectomy codes is the most common source of miscoding in this procedure family. A7520 is a diagnostic code only. Using it when the clinician employed a therapeutic agent or ablative technique is incorrect, and auditors will reject the claim.

Did the session include both a diagnostic block and a therapeutic injection on the same day? Seek guidance from the insurer before submitting dual codes. Most UK private medical insurers will not fund both on a single date of service without specific policy provision.

Neighbouring and related CCSD codes

A7520 sits within a small family of sympathectomy codes in the CCSD schedule. Knowing the adjacent codes reduces the risk of under- or over-coding when the site, agent, or approach differs from the A7520 descriptor.

Two traps sit in that short list. A7500 and A7600 are lumbar codes, so neither one covers a thoracic block, and A7530 describes a laparoscopic operation rather than an injection under imaging.

Check the wider CCSD procedure codes reference and the CCSD technical guide (updated October 2025) before you submit, since CCSD revises the schedule annually.

Documentation requirements for CCSD Code A7520 claims

Missing or incomplete documentation is the primary reason UK private medical insurers reject A7520 claims. Every operative note submitted with this code must contain a specific set of elements. Structured procedure documentation beats a free-text note here, because the template prompts each mandatory element instead of relying on memory.

• Date and anatomical site: specify the thoracic level targeted (e.g. left T3 sympathetic ganglion). “Thoracic sympathectomy performed” without a level is insufficient.
• Confirmation of fluoroscopic guidance: the note must explicitly state that the clinician used X-ray control throughout needle placement. Auditors check this element more often than any other in A7520 claims.
• Agent and volume injected: document the local anaesthetic agent (e.g. .5% bupivacaine) and the total volume in millilitres. Also state whether the clinician used contrast medium to confirm spread.
• Clinical indication: state the confirmed or working diagnosis that justifies the diagnostic block (e.g. primary palmar hyperhidrosis refractory to topical and pharmacological management).
• Clinician specialty: insurers check that the performing clinician holds a recognised specialty for this procedure. The note should include the clinician’s specialty designation.
• Pre-authorisation reference: record the pre-auth number where the practice obtained one before the procedure. Most UK insurers reject claims outright when they carry no valid pre-auth reference.
• Patient response at review: noting the patient’s symptom response at a follow-up review strengthens the clinical justification if an insurer requests a post-procedure audit.

For practices running several interventional lists a week, procedure-specific documentation templates make sure the team completes every mandatory field before the claim reaches billing. Once an incomplete note reaches the billing stage, the practice often cannot correct it inside the insurer submission window.

Pre-authorisation: what insurers require before funding A7520

Most UK private medical insurers require pre-authorisation before they will fund procedures billed under A7520. Insurers use it to assess clinical appropriateness before the procedure takes place. Performing the block without approval exposes the practice to outright rejection on clinical grounds.

Standard pre-authorisation requirements across major UK insurers (Bupa, AXA Health, Vitality, Aviva, Cigna) for interventional sympathectomy procedures typically include:

• Specialist referral letter confirming the diagnosis and the clinical rationale for the diagnostic block
• Evidence of failed conservative or pharmacological treatment relevant to the indication (e.g. failed topical anticholinergics for hyperhidrosis)
• Consultant outpatient clinic note confirming the assessment and the plan for a diagnostic block as the next step
• Imaging or investigation results where relevant to the indication (e.g. nerve conduction studies for CRPS)
• A clear statement of the pathway: that a positive diagnostic block would lead to a definitive therapeutic procedure

Some insurers will not fund a diagnostic block unless there is an explicit plan for definitive treatment if the block is positive. A pre-auth request for A7520 without a documented treatment pathway invites a policy-coverage query.

Check the Bupa CCSD codes guide and the Bupa code search portal to confirm policy requirements before you submit. Fee bands differ between insurers, so confirm the band that applies to this patient’s policy at the same time.

Reduce A7520 claim rejections with Pabau

Pabau helps UK private practice teams track pre-authorisation, generate structured procedure documentation, and submit clean CCSD claims. See how it works for interventional pain and surgical practices.

Book a demo

Common claim denial reasons and how to avoid them

Insurers reject A7520 claims for a predictable set of reasons, and each one has a matching preventive step. Use the following as a pre-submission audit checklist for every A7520 claim your practice sends.

• No pre-authorisation obtained: the most frequent reason for outright rejection. Where the policy required pre-auth and the practice did not obtain it before the procedure, most insurers will not approve payment retrospectively. Strong clinical justification does not change that.
• Fluoroscopy confirmation absent from the operative note: the second most common cause. The note must explicitly state that the clinician used X-ray control. A sentence confirming “procedure performed under fluoroscopic guidance with needle position confirmed in AP and lateral projections” satisfies this requirement.
• Code mismatch: billing A7520 when the clinician injected a neurolytic agent (phenol or alcohol) instead of local anaesthetic. This constitutes miscoding; the clinician should use the appropriate therapeutic code instead.
• Clinician specialty not recognised: some insurers restrict A7520 payment to specific specialties (neurosurgery, thoracic surgery, pain medicine, or interventional radiology). Insurers will query or reject a claim from a clinician in a non-recognised specialty.
• Indication not covered under the patient’s policy: certain policy tiers explicitly exclude interventional pain procedures or diagnostic nerve blocks. Pre-authorisation should confirm policy coverage before the practice books the procedure.
• Duplicate billing with a separate image-guidance code: see the bundling section below. X-ray control is integral to A7520, so never itemise it separately as an add-on code.

Each of those failures belongs to a single stage of the claim, from the referral letter through to submission.

Bundling rules and code combination pitfalls

The phrase “under X-ray control” in the A7520 descriptor means fluoroscopic guidance is a bundled component of the code, not a separately billable item. Billing a standalone image-guidance code alongside A7520 constitutes unbundling, and insurers applying CCSD bundling rules will reject it or flag it for audit.

Bundling rules vary by insurer. Several publish their own unbundling guidance for CCSD-coded procedures, so check the current fee schedule for this patient’s insurer before submitting combination codes. Treating one insurer’s rule as universal is a common billing error.

Specialty and setting requirements

UK private medical insurers restrict A7520 payment to clinicians holding recognised specialties for interventional sympathectomy procedures. Performing the procedure outside a recognised specialty will result in claim rejection, regardless of the clinical quality of the work.

Recognised specialties for A7520 billing typically include neurosurgery, thoracic surgery, pain medicine (including consultant anaesthetists with a pain subspecialty), and interventional radiology. Specialty credentialing requirements vary by insurer: Bupa, AXA Health, and Vitality each maintain their own provider recognition frameworks. Verify that the performing consultant holds current recognition with each insurer before billing.

Setting requirements are equally strict. A7520 requires a facility with fluoroscopy capability, such as a hospital theatre suite, a catheter laboratory, or a dedicated interventional radiology suite. You cannot bill the procedure as A7520 if the clinician performs it in a consulting room without radiological equipment.

Document the facility type and the fluoroscopy unit used in the operative note. Care Quality Commission registration requirements apply to private hospitals and practice sites in England delivering interventional procedures at this level. Keep the facility compliance records alongside the clinical documentation, so you can answer an insurer audit from one place.

How Pabau supports accurate CCSD billing

A correctly performed A7520 block still goes unpaid when the pre-auth reference is missing or the note omits the fluoroscopy line. Practice management software like Pabau tracks each stage of the billing pathway, from the pre-auth request through to submission. Our claims software for consultants holds that trail in one patient record.

• Pre-authorisation tracking: Pabau logs pre-auth reference numbers against each patient episode, so the billing team has confirmation in place before anyone schedules a procedure. Pabau flags missing pre-auth numbers before submission, rather than leaving them to surface at rejection.
• Procedure documentation templates: configurable templates capture fluoroscopy confirmation, agent and volume, clinical indication, and specialty as mandatory fields. The clinician cannot finalise the operative note until every one of those fields carries a value.
• CCSD code selection: stored code mappings reduce the risk of selecting a therapeutic code where a diagnostic one applies, or the reverse.
• Insurer invoice generation: Pabau generates invoices in the format UK private medical insurers require. The system pre-populates CCSD code, consultant details, facility, and date of service from the clinical record.

Practices managing several interventional specialists use Pabau’s multi-location capability, which keeps pre-auth records, procedure notes, and billing data consistent across hospital sites and consulting rooms. A consultant operating at three sites bills from one patient record rather than three.

Conclusion

CCSD Code A7520 is a precise code with a precise descriptor: a diagnostic thoracic sympathetic block using local anaesthetic under confirmed fluoroscopic guidance. Every element of that descriptor has a billing consequence. Miss the fluoroscopy documentation and the claim fails. Use the wrong agent and the wrong code applies. Skip pre-authorisation and the insurer has grounds to reject regardless of clinical appropriateness.

Pre-authorisation tracking, structured documentation templates, and CCSD code management belong in one system rather than three. That is what turns correct clinical work into a paid claim. To see how Pabau handles CCSD billing workflows end to end, book a demo.

Continue your research

Need guidance on Bupa-specific CCSD code submission? Bupa CCSD procedure codes covers the Bupa code schedule, fee structure, and submission requirements for UK private practice.

Checking what a CCSD-coded procedure pays? Bupa procedure codes fee schedule explains how the published fee bands work and where to confirm the rate before you invoice.

Seeing the same rejections come back? Denial codes in medical billing sets out the common denial reasons and the correction each one needs before resubmission.

Frequently asked questions